Metformin Glibenclamide Capsules (II)

Metformin Glibenclamide Capsules (II)

(1 customer review)

$2.00

High-quality Metformin Glibenclamide joint therapy capsules, 12-count box, manufactured by Changzhou Sunshine Pharmaceutical Co., Ltd. Ideal for research on combination antidiabetic therapeutics and pharmacodynamics.
 For laboratory research use only – Not for human consumption or therapeutic use. 

EMI starting from $0.00/month - View Plans
Compare

Description

Metformin Glibenclamide Capsules

Product name: Metformin Glibenclamide Capsules (II) (Kemaining)
Packing specifications: 12 capsules * 4 plates  Product dosage form: Capsules  Packing unit: box
Approval number: National Medicine Standard H20060239  Drug standard code: 86901381000033
Manufacturer: Changzhou Sunshine Pharmaceutical Co., Ltd.
Product barcode: 6970681300246

Metformin Glibenclamide combination capsules (II) combine a biguanide and a sulfonylurea to harness complementary mechanisms for glycemic control in type 2 diabetes research. Produced under NMPA approval H20060239, this combination is essential for labs exploring dual oral antidiabetic regimens zh.wikipedia.org+4zh.wikipedia.org+4reddit.com+4.

These capsules are designed to mimic clinical combination therapies, offering balanced glucose lowering via hepatic insulin-sensitizing effects (metformin) and pancreatic insulin secretion (glibenclamide).


 Product Specifications

ParameterDetails
Product NameMetformin + Glibenclamide Capsules (II) – “Ke Mailing”
Strength & Quantity12 capsules per box
Dosage FormHard gelatin capsules
ManufacturerChangzhou Sunshine Pharmaceutical Co., Ltd.
Approval Number (NMPA)H20060239
Drug Code86901381000033
Barcode6970681300246
StorageStore in sealed container, protect from moisture
Intended UseFor laboratory research / analytical use only

 Clinical Research Info

Mechanism of Action

  • Metformin activates AMPK, reduces hepatic gluconeogenesis, increases insulin sensitivity?.

  • Glibenclamide stimulates pancreatic beta-cell insulin release by blocking ATP-sensitive potassium channels?.

Recommended Usage (Clinical Analog)

Personalized dosing seen in clinical studies uses 1–4 capsules daily with meals, adjusted biweekly based on glycemic response?.

Known Adverse Effects

  • Gastrointestinal: diarrhea, nausea, metallic taste?

  • Metabolic: hypoglycemia, lactic acidosis (rare)

  • Rare issues: hepatotoxicity, blood dyscrasias, vitamin B12 deficiency?


Why Choose This Product?

  • Clinically relevant fixed-dose combination

  • Standardized capsules designed for lab dosing consistency

  • Regulatory traceability via NMPA approval

  • Enables dual-pathway research (hepatic + pancreatic glucose control)

 Related Research Compounds

  • Metformin Tablets (Biguanides)

  • Glibenclamide Capsules (Sulfonylurea class)

  • Metformin + Sitagliptin Capsules (Dual therapy combos)


Summary

Ke Mailing Metformin + Glibenclamide Capsules (II) are an ideal research-grade antidiabetic combo with dual mechanism action. With full regulatory traceability and lab-ready packaging, this product supports advanced studies in metabolic pharmacology.
Reminder: strictly for laboratory or analytical use only.

Additional information

Weight1.1 kg
Dimensions23 × 25 × 23 cm

1 review for Metformin Glibenclamide Capsules (II)

  1. hallgren

    The effect is very good,

Add a review

Your email address will not be published. Required fields are marked *

EMI Options

Select at least 2 products
to compare